← Eichor
Condition: Drug Dose Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Drug Dose

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study Evaluating the Safety, Efficacy and Pharmacokinetics of SYH9089 Injection in Patients Undergoing Abdominal Surgery
Phase 1 · 1 location(s) · CSPC Ouyi Pharmaceutical Co., Ltd. · NCT07519109Safety Evaluation of Gene Therapy Drug in the Treatment of Primary Hypertriglyceridemic Patients With Recurrent Pancreat
Phase 1 · 1 location(s) · GeneCradle Inc · NCT05860569Confirmatory Clinical Study in Active Ulcerative Colitis
Phase 2 · 16 location(s) · MRM Health NV · NCT07296315Study of XB010 in Subjects With Solid Tumors
Phase 1 · 20 location(s) · Exelixis · NCT06545331Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease
Phase 4 · 2 location(s) · Wei Zhao · NCT03844360A Phase I/IIa, Open-label, Single-center, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability,
EARLY_Phase 1 · 4 location(s) · Suzhou Immunofoco Biotechnology Co., Ltd · NCT07376642A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of
Phase 1/Phase 2 · 12 location(s) · Ipsen · NCT07213817BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Phase 1/Phase 2 · 25 location(s) · BioInvent International AB · NCT04752826Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-release Drugs
Phase 4 · 9 location(s) · Edward Geissler · NCT06268769A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1
Phase 1 · 11 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07390955Dynamic Treatment Regiments for Glucocorticoid Tapering
Phase 2 · 2 location(s) · VA Office of Research and Development · NCT06072768A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body of Hea
Phase 1 · 1 location(s) · Pfizer · NCT06994897Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Live
Phase 4 · 18 location(s) · University Hospital, Limoges · NCT06354179Fast Acute Sedation at Intensive Care vs. High-dose i.v. Anti-seizure Medication for Treatment of Non-convulsive Status
Phase 3 · 5 location(s) · University of Southern Denmark · NCT05263674A Study of EBC-129 in Advanced Solid Tumours
Phase 1 · 5 location(s) · EDDC (Experimental Drug Development Centre), A*STAR Research · NCT05701527This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Tor
Phase 1 · 3 location(s) · Zumutor Biologics Inc. · NCT06451497A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers
Phase 1 · 7 location(s) · Light Chain Bioscience - Novimmune SA · NCT05403554Safety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive Dyskinesia
Phase 1/Phase 2 · 1 location(s) · Luye Pharma Group Ltd. · NCT06731868Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06387121Telecommunication Technology-based Online Survey
Phase N/A · 1 location(s) · Tomsk National Research Medical Center of the Russian Academ · NCT06159699A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Benefi
Phase 1/Phase 2 · 68 location(s) · BioNTech SE · NCT07111520Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors
Phase 1 · 10 location(s) · Hanmi Pharmaceutical Company Limited · NCT06234397A Study With ABL103 in Subjects With Advanced or Metastatic Solid Tumors
Phase 1 · 3 location(s) · ABL Bio, Inc. · NCT06126666Study of JK06 in Patients With Unresectable Locally Advanced or Metastatic Cancer
Phase 1/Phase 2 · 14 location(s) · Salubris Biotherapeutics Inc · NCT06667960A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
Phase 1/Phase 2 · 17 location(s) · Biohaven Therapeutics Ltd. · NCT06384807Novel Triple-dose Tuberculosis Retreatment Regimen
Phase 3 · 1 location(s) · Institute of Tropical Medicine, Belgium · NCT04260477To Test a New Drug (LCFA-01) for Safety and PK in Healthy Adults for Bacterial Vaginosis Infection.
Phase 1 · 1 location(s) · Massachusetts General Hospital · NCT07514416A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Fro
Phase 1/Phase 2 · 19 location(s) · AviadoBio Ltd · NCT06064890A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works
Phase 1/Phase 2 · 11 location(s) · Regeneron Pharmaceuticals · NCT06413680A Phase 1 Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
Phase 1 · 8 location(s) · NEOK Bio, Inc. · NCT07612176
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.